Shandong Weigao Medical Polymer ROA 2012-2018 | SHWGF
Current and historical return on assets (ROA) values for Shandong Weigao Medical Polymer (SHWGF) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Shandong Weigao Medical Polymer ROA for the three months ending June 30, 2018 was 0.00%.
|Shandong Weigao Medical Polymer ROA - Return on Assets Historical Data
||TTM Net Income
||Return on Assets
||Medical Products Manufacturing
Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of single-use medical devices. Single use products offered by the Company includes syringes, blood bags and blood component segregator consumables, blood sampling products, dental and anesthetic consumables, and prefilled syringes for pre-pack medication and etc. It also offers orthopedic materials and instruments like trauma products of steel plates and screws, spinal implants, and artificial joints; blood purification consumables, such as puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, PVC granules, and related consumables, as well as immunity adsorption products for the treatment of immune system diseases; and cardiovascular stents, including drug eluting stents and balloons. Shandong Weigao Group Medical Polymer Company is based in Weihai, the People's Republic of China.